01 1Sun Pharmaceutical Industries Limited
01 1EPINEPHRINE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-01-05
Pay. Date : 2021-12-30
DMF Number : 28617
Submission : 2014-09-18
Status : Active
Type : II
20
Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is EPINEPHRINE USP, with a corresponding US DMF Number 28617.
Remarkably, this DMF maintains an Active status since its submission on September 18, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 05, 2022, and payment made on December 30, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
